Poor Survival of Females with Bladder Cancer is Limited to Those Aged 70 Years or Over: a Population-wide Linkage Study, New South Wales, Australia

Overview

Journal Cancer Med

Specialty Oncology

Date 2015 Apr 28

PMID 25914165

Citations 8

Authors

Manish I Patel

Albert Bang

David Gillett

Rajkumar Cheluvappa

David P Smith

Affiliations

Soon will be listed here.

Abstract

Although men are diagnosed with bladder cancer (BC) with a rate three times higher than women, women experience poorer survival. The cause of this gender difference is not clear. The aim of this study was to investigate the discrepancy in survival from BC by gender and explore potential explanations for the difference using a population-wide linkage study. Using the New South Wales (NSW) Central Cancer Registry, all invasive BC cases diagnosed between 2001 and 2009 were identified. Records were linked to the NSW Admitted Patient Data Collection (APDC), to retrieve treatment details, and to the Registry of Births Deaths and Marriages and Australian Bureau of Statistics to obtain death details. A total of 5377 new cases of BC were identified. No differences were identified in the proportions of patients presenting at different stages between genders. However, disease-specific survival (DSS) was worse for females compared to males with localized and regional disease (P < 0.05). This difference was only apparent in individuals aged ≥ 70 years and no difference was identified in those younger. Multivariable Cox-regression analysis of the cohort of individuals aged ≥ 70 years revealed that stage, age, comorbidity, and sex remained independent variables (P < 0.05) predicting DSS. In a population wide analysis, females aged 70 years or more suffer worse DSS compared to males. The differences are not accounted for by stage at presentation or comorbidity and are independent of age. BC in postmenopausal females may be biologically more aggressive.

Citing Articles

Enhancing Therapeutic Efficacy and Safety of Immune Checkpoint Inhibition for Bladder Cancer: A Comparative Analysis of Injectable vs. Intravesical Administration.

Tyagi P, Hafron J, Kaufman J, Chancellor M Int J Mol Sci. 2024; 25(9).

PMID: 38732167 PMC: 11084450. DOI: 10.3390/ijms25094945.

Survival influence of gender on 42,345 patients with gastric cardia adenocarcinoma.

Xu R, Zhao X, Song X, Lei L, Zhong K, Han W J Cancer Res Clin Oncol. 2022; 149(8):5205-5217.

PMID: 36376616 PMC: 10349744. DOI: 10.1007/s00432-022-04470-8.

Prognostic Factors for Bladder Cancer Patients in Malaysia: A Population-Based Study.

Nik Ab Kadir M, Mohd Hairon S, Yaacob N, Ab Manan A, Ali N Int J Environ Res Public Health. 2022; 19(5).

PMID: 35270721 PMC: 8910605. DOI: 10.3390/ijerph19053029.

Survival and Characteristics of Bladder Cancer: Analysis of the Malaysian National Cancer Registry.

Nik Ab Kadir M, Mohd Hairon S, Yaacob N, Ab Manan A, Ali N Int J Environ Res Public Health. 2021; 18(10).

PMID: 34069096 PMC: 8156894. DOI: 10.3390/ijerph18105237.

ROC-1, P21 and CAIX as markers of tumor aggressiveness in bladder carcinoma in Egyptian patients.

Al-Sharaky D, Kandil M, Aiad H, El-Hosary E, Alagizy H, Elshenawy M Diagn Pathol. 2020; 15(1):33.

PMID: 32264924 PMC: 7137342. DOI: 10.1186/s13000-020-00947-7.

References

Kluth L, Rieken M, Xylinas E, Kent M, Rink M, Roupret M . Gender-specific differences in clinicopathologic outcomes following radical cystectomy: an international multi-institutional study of more than 8000 patients. Eur Urol. 2013; 66(5):913-9. DOI: 10.1016/j.eururo.2013.11.040. View

Saez S, Martin P . Evidence of estrogen receptors in the trigone area of human urinary bladder. J Steroid Biochem. 1981; 15:317-20. DOI: 10.1016/0022-4731(81)90291-0. View

Zhuang Y, Blauer M, Tammela T, Tuohimaa P . Immunodetection of androgen receptor in human urinary bladder cancer. Histopathology. 1997; 30(6):556-62. DOI: 10.1046/j.1365-2559.1997.5610801.x. View

Prout Jr G, Wesley M, Yancik R, Ries L, Havlik R, Edwards B . Age and comorbidity impact surgical therapy in older bladder carcinoma patients: a population-based study. Cancer. 2005; 104(8):1638-47. DOI: 10.1002/cncr.21354. View

McGrath M, Michaud D, De Vivo I . Hormonal and reproductive factors and the risk of bladder cancer in women. Am J Epidemiol. 2005; 163(3):236-44. DOI: 10.1093/aje/kwj028. View

Taub D, Hollenbeck B, Cooper K, Dunn R, Miller D, Taylor J . Racial disparities in resource utilization for cystectomy. Urology. 2006; 67(2):288-93. DOI: 10.1016/j.urology.2005.09.003. View

Miyamoto H, Yang Z, Chen Y, Ishiguro H, Uemura H, Kubota Y . Promotion of bladder cancer development and progression by androgen receptor signals. J Natl Cancer Inst. 2007; 99(7):558-68. DOI: 10.1093/jnci/djk113. View

Scelo G, Brennan P . The epidemiology of bladder and kidney cancer. Nat Clin Pract Urol. 2007; 4(4):205-17. DOI: 10.1038/ncpuro0760. View

Herr H . Age and outcome of superficial bladder cancer treated with bacille Calmette-Guérin therapy. Urology. 2007; 70(1):65-8. DOI: 10.1016/j.urology.2007.03.024. View

10.

Heiner J, Terris M . Effect of advanced age on the development of complications from intravesical bacillus Calmette-Guérin therapy. Urol Oncol. 2008; 26(2):137-40. DOI: 10.1016/j.urolonc.2007.04.005. View

11.

Horstmann M, Witthuhn R, Falk M, Stenzl A . Gender-specific differences in bladder cancer: a retrospective analysis. Gend Med. 2008; 5(4):385-94. DOI: 10.1016/j.genm.2008.11.002. View

12.

Tracey E, Roder D, Luke C, Bishop J . Bladder cancer survivals in New South Wales, Australia: why do women have poorer survival than men?. BJU Int. 2009; 104(4):498-504. DOI: 10.1111/j.1464-410X.2009.08527.x. View

13.

Shariat S, Sfakianos J, Droller M, Karakiewicz P, Meryn S, Bochner B . The effect of age and gender on bladder cancer: a critical review of the literature. BJU Int. 2009; 105(3):300-8. PMC: 4315315. DOI: 10.1111/j.1464-410X.2009.09076.x. View

14.

Scosyrev E, Golijanin D, Wu G, Messing E . The burden of bladder cancer in men and women: analysis of the years of life lost. BJU Int. 2011; 109(1):57-62. DOI: 10.1111/j.1464-410X.2011.10318.x. View

15.

Mitra A, Skinner E, Schuckman A, Quinn D, Dorff T, Daneshmand S . Effect of gender on outcomes following radical cystectomy for urothelial carcinoma of the bladder: a critical analysis of 1,994 patients. Urol Oncol. 2013; 32(1):52.e1-9. DOI: 10.1016/j.urolonc.2013.08.007. View

16.

Tracey E, Watt H, Currow D, Young J, Armstrong B . Investigation of poorer bladder cancer survival in women in NSW, Australia: a data linkage study. BJU Int. 2013; 113(3):437-48. DOI: 10.1111/bju.12496. View

17.

Cheluvappa R, Smith D, Cerimagic S, Patel M . A comprehensive evaluation of bladder cancer epidemiology and outcomes in Australia. Int Urol Nephrol. 2014; 46(7):1351-60. DOI: 10.1007/s11255-014-0643-z. View

18.

Kaushik D, Frank I, Eisenberg M, Cheville J, Tarrell R, Thapa P . Gender-specific survival following radical cystectomy for pT4 bladder cancer. World J Urol. 2013; 32(6):1433-9. DOI: 10.1007/s00345-013-1232-y. View

19.

Mungan N, Kiemeney L, van Dijck J, van der Poel H, Witjes J . Gender differences in stage distribution of bladder cancer. Urology. 2000; 55(3):368-71. DOI: 10.1016/s0090-4295(99)00481-1. View

20.

Puente D, Malats N, Cecchini L, Tardon A, Garcia-Closas R, Serra C . Gender-related differences in clinical and pathological characteristics and therapy of bladder cancer. Eur Urol. 2003; 43(1):53-62. DOI: 10.1016/s0302-2838(02)00496-7. View